1. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.
   Maryam Tahmasebi Birgani et al, 2017, Int J Mol Sci CrossRef
2. Small Molecules for Neural Stem Cell Induction
   Donghui Liu et al, 2018, Stem Cells and Development CrossRef
3. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition
   Chunmei Guo et al, 2018, Sci Rep CrossRef
4. SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells
   Han-Heom Na et al, 2018, Biochemical and Biophysical Research Communications CrossRef
5. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
   Eunjeong Kim et al, 2018, Hepatology CrossRef
6. Role of MAPK/MNK1 signaling in virus replication
   Ram Kumar et al, 2018, Virus Research CrossRef
7. Biliverdin reductase and bilirubin in hepatic disease
   Lauren Weaver et al, 2018, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
8. Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment
   Rui Zhang et al, 2018, BMC Cancer CrossRef
9. Regions of multistationarity in cascades of Goldbeter–Koshland loops
   Magalí Giaroli et al, 2018, J. Math. Biol. CrossRef
10. Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer Drugs
    Manjula Vinayak, 2018, Nutrition and Cancer CrossRef
11. A review of computational approaches for analysis of hepatitis C virus-mediated liver diseases
    Sumanta Ray et al, 2017 CrossRef
12. null
    Venice Wing Tung Ho et al, 2019 CrossRef
13. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro
    Wei-Ting Chen et al, 2019, IJMS CrossRef
14. Myelodysplastic syndrome related alterations of MAPK signaling in the of bone marrow of experimental mice including stem/progenitor compartment
    Suchismita Daw et al, 2019, Acta Histochemica CrossRef
15. Urgent Necessity for Standardized and Evidence Based Plant Immunomodulators (Such As Rice Bran Arabinoxylan Concentrate/MGN-3) for the Tumor Research
    Tibor Hajto, 2018, IJCAM CrossRef
16. Cylindrospermopsin induces cellular stress and activation of ERK1/2 and p38 MAPK pathways in adult human liver stem cells
    Jan Raška et al, 2019, Chemosphere CrossRef
17. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1
    Jingzhe Zhang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
18. The environmental obesogen bisphenol A increases macrophage self-renewal
    Grace Ampem et al, 2019, Cell Tissue Res CrossRef
19. Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade
    Mohamed Amine Benchaib et al, 2019, Front. Bioeng. Biotechnol. CrossRef
20. Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish
    Chuan Yan et al, 2017, Sci Rep CrossRef
21. Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
    Elodie Villa et al, 2019, Cancers CrossRef
22. Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma
    Jiajia He et al, 2019, Cancer Letters CrossRef
23. AKT and ERK dual inhibitors: The way forward?
    Zhe Cao et al, 2019, Cancer Lett CrossRef
24. A benchmark dataset for analyzing and visualizing the dynamic epiproteome
    Sandeep Kaur et al, 2019, Data in Brief CrossRef
25. null
    Aniket Kumar Bansal et al, 2019 CrossRef
26. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway
    Jin Sun et al, 2019, J Cell Biochem CrossRef
27. Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
    Cristian Scheau et al, 2019, Molecules CrossRef
28. RAS in pancreatic cancer
    Simone Lanfredini et al, 2019, Biochm. Soc. Trans. CrossRef
29. Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression
    Maryam Ranjpour et al, 2019, ACAMC CrossRef
30. Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway
    Cindy Kundlacz et al, 2019, J Virol CrossRef
31. Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
    Zhiqin Li et al, 2019, Cancer Cell Int CrossRef
32. JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression
    Haiming Chen et al, 2019, Br J Haematol CrossRef
33. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo
    Xiaoni Liu et al, 2017 CrossRef
34. Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
    M. V. Novikova et al, 2017, Biochemistry Moscow CrossRef
35. Lectin BS-I inhibits cell migration and invasionviaAKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma
    Qiang Jian et al, 2018, J. Cell. Mol. Med. CrossRef
36. Mutation-Specific Mechanisms of Hyperactivation of Noonan Syndrome SOS Molecules Detected with Single-molecule Imaging in Living Cells
    Yuki Nakamura et al, 2017, Sci Rep CrossRef
37. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’
    Cyriac Abby Philips et al, 2019 CrossRef
38. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
    Farzad Rahmani et al, 2019, J Cell Physiol CrossRef
39. Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
    Saharnaz Sarlak et al, 2019, Seminars in Cell & Developmental Biology CrossRef
40. Ursonic acid exerts inhibitory effects on matrix metalloproteinases via ERK signaling pathway
    Juhyeon Son et al, 2019, Chemico-Biological Interactions CrossRef
41. The multi-faceted functioning portrait of LRF/ZBTB7A
    Caterina Constantinou et al, 2019, Hum Genomics CrossRef
42. Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.
    Nancy S Younis et al, 2019, Sci Rep CrossRef
43. Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met
    Mohamed Y. Zaky et al, 2019, Archives of Biochemistry and Biophysics CrossRef
44. Activation of extracellular signal‐regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes
    Takuya Minagawa et al, 2019, Hepatol Res CrossRef
45. Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer
    Sandeep Kumar et al, 2020, Pharmaceuticals CrossRef
46. Mechanism of a Novel Camptothecin-Deoxycholic Acid Derivate Induced Apoptosis against Human Liver Cancer HepG2 Cells and Human Colon Cancer HCT116 Cells
    Linxia Xiao et al, 2020, PRA CrossRef
47. null
    Filipa Lopes-Coelho et al, 2020 CrossRef
48. Degradation of HOX Transcript Antisense RNA Provoked Apoptosis and Necrosis in Human Ovarian Cancer Cells
    Mahsa Sabet et al, 2020, Indian J Gynecol Oncolog CrossRef
49. Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells
    Jung Hwan Yoon et al, 2020, Gastric Cancer CrossRef
50. Loss of c‐Jun N‐terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
    Francisco Javier Cubero et al, 2020, Hepatol Commun CrossRef
51. Three‐dimensional culture models to study drug resistance in breast cancer
    Madeline F. Fisher et al, 2020, Biotechnology and Bioengineering CrossRef
52. An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics.
    Youssef W Naguib et al, 2021, Drug Deliv Transl Res CrossRef
53. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
    Yanling Liu et al, 2020, Nanoscale Res Lett CrossRef
54. β‐Arrestin1 is involved in hepatocellular carcinoma metastasis via extracellular signal‐regulated kinase‐mediated epithelial–mesenchymal transition
    Xuan Xu et al, 2020, Journal of Gastroenterology and Hepatology CrossRef
55. COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma.
    Yu-De Chu et al, 2020, Cancers (Basel) CrossRef
56. Engineering Cell‐Derived Matrices: From 3D Models to Advanced Personalized Therapies
    Gerard Rubi‐Sans et al, 2020, Adv. Funct. Mater. CrossRef
57. SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway
    Cuisheng Zhang et al, 2019, Mol Med Report CrossRef
58. Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line
    Wei Wang et al, 2018, Mol Med Report CrossRef
59. Valosin‑containing protein promotes metastasis of osteosarcoma through autophagy induction and anoikis inhibition via the ERK/NF‑κβ/beclin‑1 signaling pathway
    Xin Long et al, 2019, Oncol Lett CrossRef
60. Bifidobacterium breve UCC2003 Induces a Distinct Global Transcriptomic Program in Neonatal Murine Intestinal Epithelial Cells
    Raymond Kiu et al, 2020, iScience CrossRef
61. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance
    Behnam Alipoor et al, 2020, Mol Biol Rep CrossRef
62. Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment
    Juliana F. Vilachã et al, 2020, Crystals CrossRef
63. Structure-Dependent Effects of Phthalates on Intercellular and Intracellular Communication in Liver Oval Cells
    Lucie Čtveráčková et al, 2020, IJMS CrossRef
64. Non-hormonal mediators of uterine fibroid growth
    Esra Cetin et al, 2020 CrossRef
65. Sinonasal Inverted Papilloma: A Narrative Review
    Ila B. Upadhya et al, 2020, Indian J Otolaryngol Head Neck Surg CrossRef
66. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL
    Abbasi Majid et al, 2020, Front. Mol. Biosci. CrossRef
67. Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
    Emanuele Rinninella et al, 2020, Nutrients CrossRef
68. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells
    Min Hee Yang et al, 2020, IJMS CrossRef
69. Afadin (AF6) in cancer progression: A multidomain scaffold protein with complex and contradictory roles
    Jennifer Huxham et al, 2020, BioEssays CrossRef
70. Signal Transduction in Hepatocellular Carcinoma: Insights from Zebrafish
    Madan Mohan Udaya Kumar et al, 2020, Proc. Singapore Natl. Acad. Sci. CrossRef
71. LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies
    Giovanna Revilla et al, 2020, Seminars in Cancer Biology CrossRef
72. REGULATION OF CELLULAR ANABOLISM BY MTOR: OR HOW I LEARNED TO STOP WORRYING AND LOVE TRANSLATION
    J. William Deaver et al, 2020, Sports Medicine and Health Science CrossRef
73. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects
    Aryendu Kumar Saini et al, 2020, Mol Med CrossRef
74. A Rab escort protein regulates the MAPK pathway that controls filamentous growth in yeast
    Sheida Jamalzadeh et al, 2020, Sci Rep CrossRef
75. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation
    Wei-Chung Hsu et al, 2020, Phytomedicine CrossRef
76. Effect of Periodontitis and Scaling and Root Planing on Risk of Pharyngeal Cancer: A Nested Case—Control Study
    Ping-Ju Chen et al, 2020, IJERPH CrossRef
77. Three new 3-formyl-2-arylbenzofurans from Itea yunnanensis and their anti-hepatocellular carcinoma effects
    Tian-Qiong Lang et al, 2020, Natural Product Research CrossRef
78. Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents
    Asbiel Hasbum et al, 2021, Future Medicinal Chemistry CrossRef
79. Increase in PPARγ inhibitory phosphorylation by Fetuin—A through the activation of Ras-MEK-ERK pathway causes insulin resistance
    Snehasis Das et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
80. The differential expression of Promyelocytic Leukemia (PML) and retinoblastoma (RB1) genes in breast cancer
    Banashree Bondhopadhyay et al, 2021, Meta Gene CrossRef
81. The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy
    Gianni Frascotti et al, 2021, Cancers CrossRef
82. A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on treatment of Tanshinone Ⅰ Against Ischemic Stroke in Mouse
    Jiajia Liu et al, 2021, Journal of Ethnopharmacology CrossRef
83. Comparative anticancer activities of Ficus carica and Ficus salicifolia latex in MDA-MB-231 cells
    Fatma Mousa AlGhalban et al, 2021, Saudi Journal of Biological Sciences CrossRef
84. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer
    Agata Binienda et al, 2020, ACAMC CrossRef
85. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis
    Hang Xing et al, 2021, J Mol Neurosci CrossRef
86. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
    Jiejun Hu et al, 2021, Front. Oncol. CrossRef
87. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
    Fatemeh Khojasteh Poor et al, 2021, BD CrossRef
88. Biological Therapy with Complementary and Alternative Medicine in Innocuous Integrative Oncology: A Case of Cervical Cancer
    Elvin Peter Chizenga et al, 2021, Pharmaceutics CrossRef
89. Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
    Noreen McBrearty et al, 2021, Neoplasia CrossRef
90. Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma
    Gundula Streubel et al, 2021, Sci Rep CrossRef
91. Angiogenic Properties of Placenta-Derived Extracellular Vesicles in Normal Pregnancy and in Preeclampsia
    Natalia Gebara et al, 2021, IJMS CrossRef
92. LncRNA H19 Upregulation Participates in the Response of Glioma Cells to Radiation
    Yanbei Kuang et al, 2021, BioMed Research International CrossRef
93. Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition
    Malgorzata Jozkowiak et al, 2021, IJMS CrossRef
94. null
    Syed Zameer Hussain et al, 2021 CrossRef
95. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
    Hyuk Moon et al, 2021, Cancers CrossRef
96. Seaweed Components as Potential Modulators of the Gut Microbiota
    Emer Shannon et al, 2021, Marine Drugs CrossRef
97. null
    Diamantis I. Tsilimigras et al, 2020 CrossRef
98. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
    Pin Zhao et al, 2021, Front. Oncol. CrossRef
99. Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice
    Aml I. Mekkawy et al, 2021, International Journal of Pharmaceutics CrossRef
100. Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma
     Nobuhiko Asakura et al, 2021, IJMS CrossRef
101. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression
     Sameh Saber et al, 2021, Biomedicine & Pharmacotherapy CrossRef
102. Low concentrations of 4-ABP promote liver carcinogenesis in human liver cells and a zebrafish model
     Heng-Dao Lin et al, 2021, Journal of Hazardous Materials CrossRef
103. Perspective: The Mechanobiology of Hepatocellular Carcinoma
     Abigail E. Loneker et al, 2021, Cancers CrossRef
104. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma
     Xu Chao et al, 2021, BioMed Research International CrossRef
105. LncRNA TP53TG1 Promotes the Growth and Migration of Hepatocellular Carcinoma Cells via Activation of ERK Signaling
     Qingchun Lu et al, 2021, ncRNA CrossRef
106. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
     Zahra Torki et al, 2021, Cancer Chemother Pharmacol CrossRef
107. YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS
     Jun Guo et al, 2021, Front. Pharmacol. CrossRef
108. The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles
     Kanawat Wiwatchaitawee et al, 2021, Drug Deliv. and Transl. Res. CrossRef
109. Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
     Martha Dillon et al, 2021, Cancers CrossRef
110. Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment
     Verica Vasic et al, 2021, Genes CrossRef
111. The Biomimetic Extracellular Matrix: a Therapeutic Tool for Breast Cancer Research
     Marta Tamayo-Angorrilla et al, 2021, Translational Research CrossRef
112. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics
     Jaishree Pandian et al, 2022, Experimental Cell Research CrossRef
113. The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
     Elham Zeinalzadeh et al, 2021, Front. Genet. CrossRef
114. Chemopreventive and hepatoprotective effects of genistein via inhibition of oxidative stress and the versican/PDGF/PKC signaling pathway in experimentally induced hepatocellular carcinoma in rats by thioacetamide.
     Yousra M El-Far et al, 2022, Redox Rep CrossRef
115. Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest
     Deokbae Park, 2022, Biological & Pharmaceutical Bulletin CrossRef
116. Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma
     Yang Hai et al, 2022, European Journal of Medicinal Chemistry CrossRef
117. null
     Gayatri Gouda et al, 2022 CrossRef
118. Biomarker LEPRE1 induces pelitinib-specific drug responsiveness by regulating ABCG2 expression and tumor transition states in human leukemia and lung cancer
     A-Ram Lee et al, 2022, Sci Rep CrossRef
119. Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma
     Ayşe Ufuk et al, 2022, Cancers CrossRef
120. Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
     Ying Zhang et al, 2022, npj Breast Cancer CrossRef
121. Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography
     Sisir Nandi et al, 2022, ACAMC CrossRef
122. null
     Fayyaz Rasool et al, 2022 CrossRef
123. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action
     Abdul Waheed Khan et al, 2022, Cells CrossRef
124. The roles of epidermal growth factor receptor in viral infections
     Kah Man Lai et al, 2022, Growth Factors CrossRef
125. Antiangiogenic and apoptotic effects of benzyl caffeate on human umbilical vein endothelial cells (HUVECs) and chick embryo chorioallantoic membrane (CAM): In vitro and in vivo models
     Ho-Jeong Bang et al, 2022, Journal of Functional Foods CrossRef
126. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.
     Hong-Beom Park et al, 2022, Biochim Biophys Acta Rev Cancer CrossRef
127. Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line
     Muhammad Atif et al, 2022, Saudi Journal of Biological Sciences CrossRef
128. The regulation of shrimp metabolism by the white spot syndrome virus (WSSV)
     Ramya Kumar et al, 2022, Reviews in Aquaculture CrossRef
129. Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
     Julia Koch-Heier et al, 2022, Front. Pharmacol. CrossRef
130. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma
     Tao Wang et al, 2021, CMC CrossRef
131. SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19?
     Morteza Ghasemnejad-Berenji et al, 2021, Pharmacology CrossRef
132. GANT61/BI-847325 combination: a new hope in lung cancer treatment
     Abdel Halim M. El-Kishky et al, 2022, Med Oncol CrossRef
133. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
     Naoshad Muhammad et al, 2022, Cells CrossRef
134. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
     Hao Qin et al, 2022, Front. Oncol. CrossRef
135. Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma
     Sumit Siddharth et al, 2022, IJMS CrossRef
136. Nutraceuticals Derived from Dietary Spices as Candidate Molecules in Targeting Glioma Signaling Pathways
     Vinitha Rani et al, 2022, Rev. Bras. Farmacogn. CrossRef
137. A Comprehensive Review on the Therapeutic Versatility of Imidazo [2,1-b]thiazoles
     Mohd Adil Shareef et al, 2020, CMC CrossRef
138. Potential Therapeutic Strategies to Combat HCC
     Sidra Altaf et al, 2022, CMP CrossRef
139. Computational analysis of natural product B-Raf inhibitors
     Sumiran Chettri et al, 2022, Journal of Molecular Graphics and Modelling CrossRef
140. NEIL3 promotes hepatoma epithelial–mesenchymal transition by activating the BRAF / MEK / ERK / TWIST signaling pathway
     Hui‐Huang Lai et al, 2022, The Journal of Pathology CrossRef
141. Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer
     Xueli Tian et al, 2022, Mol Cancer CrossRef
142. Periodontitis and Its Inflammatory Changes Linked to Various Systemic Diseases: A Review of Its Underlying Mechanisms
     Ruchi Bhuyan et al, 2022, Biomedicines CrossRef
143. Exploring CDKs, Ras-ERK, and PI3K-Aktin Abnormal Signaling and Cancer
     Sisir Nandi et al, 2022, J. Can. Res. Updates CrossRef
144. Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p
     Samer A. Tadros et al, 2022, IJMS CrossRef
145. Exploration of Chemopreventive Potential of Linalool in Targeting Lung Cancer Biomarkers
     Jyoti Singh et al, 2022, EMIDDT CrossRef
146. MAP kinase phosphatase MKP-1 regulates p-ERK1/2 signaling pathway with fluoride treatment.
     Lin Zhao et al, 2021, Biochem Biophys Res Commun CrossRef
147. Jia-Wei-Si-Miao-Yong-An Fang stimulates the healing of acute radiation-induced cutaneous wounds through MAPK/ERK pathway
     Yin Wang et al, 2023, Journal of Ethnopharmacology CrossRef
148. Computational assessment of chemicals from Morinda citrifolia as potential inhibitors of B-Raf kinase in hepatocellular carcinoma treatment
     Chinenye Jane Ugwah-Oguejiofor et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
149. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
     Hanie Abolfathi et al, 2023, Respir Res CrossRef
150. Nanocarrier of Pin1 inhibitor based on supercritical fluid technology inhibits cancer metastasis by blocking multiple signaling pathways
     Fengzhu Zhang et al, 2023 CrossRef
151. Prediction of liver cancer prognosis based on immune cell marker genes
     Jianfei Liu et al, 2023, Front. Immunol. CrossRef
152. The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis
     Carina Proença et al, 2023, Medicinal Research Reviews CrossRef
153. Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
     Alexandru Vasincu et al, 2023, Biomedicines CrossRef
154. COENZYME Q0 INHIBITS CELL PROLIFERATION AND MODULATES MAPK AND AKT SIGNALLING PATHWAYS IN HUMAN CHRONIC MYELOID LEUKEMIA K562 CELLS
     Ecem KAYA SEZGİNER et al, 2023, Ankara Ecz. Fak. Derg. CrossRef
155. Hydrogen sulfide suppresses H2O2-induced proliferation and migration of HepG2 cells through Wnt/β-catenin signaling pathway
     Hongzhi Zhao et al, 2023, Med Oncol CrossRef
156. Houttuynia cordata Thunb. Hexane fraction induces MDA-MB-231 cell apoptosis via caspases, ER stress, cell cycle arrest and attenuated Akt/ERK signaling
     Pitsinee Inthi et al, 2023, Heliyon CrossRef
157. Biological functions and research progress of eIF4E
     Xiaocong Chen et al, 2023, Front. Oncol. CrossRef
158. Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
     Sophie Klemm et al, 2023, BMC Cancer CrossRef
159. Role of granulocyte colony stimulating factor in the treatment of cirrhosis of liver: a systematic review
     Siddheesh Rajpurohit et al, 2023, J Int Med Res CrossRef
160. A Regulator Role for the ATP-Binding Cassette Subfamily C Member 6 Transporter in HepG2 Cells: Effect on the Dynamics of Cell–Cell and Cell–Matrix Interactions
     Ilenia Matera et al, 2023, IJMS CrossRef
161. A Review on Inhibitory Action of Tyrosine Kinase Inhibitors (TKI) by Curbing the ATP-Tyrosine Kinase Interactions
     Vanktesh Kumar et al, 2023, CST CrossRef
162. Role of Plant-Based Anticancer Compounds in Treatment of Breast Cancer
     Ankita Thakur et al, 2023, Curr. Pharmacol. Rep. CrossRef
163. Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells
     Preety Rawal et al, 2023, Liver International CrossRef
164. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections
     Ali Shojaeian et al, 2024, J Cancer Metastasis Treat CrossRef
165. Unraveling Molecular Signatures in Rare Bone Tumors and Navigating the Cancer Pathway Landscapes for Targeted Therapeutics
     Atif Khurshid Wani et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
166. Novel pH responsive hesperidin nanoformulation exerts anticancer activity on lung adenocarcinoma cells by targeting Akt/mTOR and MEK/ERK pathways
     S. R. Pavan et al, 2024, Journal of Materials Research CrossRef
167. Dioon rzedowskii: An antioxidant, antibacterial and anticancer plant extract with multi-faceted effects on cell growth and molecular signaling
     Walaa A. Negm et al, 2024, International Immunopharmacology CrossRef